Assignee
ONCTERNAL THERAPEUTICS INC
US·13 granted patents·4 pending applications·38 citations·filing 2016–2025
Top patents by PatentIndex Score
17 records- 0192US11285132B2Uses of indolinone compoundsONCTERNAL THERAPEUTICS INC·Filed 2020·Granted Mar 29, 2022·3 cites·8 claims
- 0292US9987251B2Indolinone compounds and uses thereofONCTERNAL THERAPEUTICS INC·Filed 2016·Granted Jun 5, 2018·8 cites·18 claims
- 0391US9895352B2Indolinone compounds and uses thereofONCTERNAL THERAPEUTICS INC·Filed 2016·Granted Feb 20, 2018·6 cites·16 claims
- 0490US12161626B2Uses of indolinone compoundsONCTERNAL THERAPEUTICS INC·Filed 2022·Granted Dec 10, 2024·1 cites·20 claims
- 0589US10646470B2Uses of indolinone compoundsONCTERNAL THERAPEUTICS INC·Filed 2018·Granted May 12, 2020·3 cites·8 claims
- 0688US11591290B2Selective androgen receptor degrader (SARD) ligands and methods of use thereofONCTERNAL THERAPEUTICS INC·Filed 2020·Granted Feb 28, 2023·2 cites·6 claims
- 0788US10159660B2Uses of indolinone compoundsONCTERNAL THERAPEUTICS INC·Filed 2017·Granted Dec 25, 2018·6 cites·8 claims
- 0886US9822122B2Indoline analogs and uses thereofONCTERNAL THERAPEUTICS INC·Filed 2017·Granted Nov 21, 2017·4 cites·10 claims
- 0985US11084811B2Compounds for treatment of cancerONCTERNAL THERAPEUTICS INC·Filed 2019·Granted Aug 10, 2021·2 cites·11 claims
- 1082US10711008B2Indoline analogs and uses thereofONCTERNAL THERAPEUTICS INC·Filed 2019·Granted Jul 14, 2020·1 cites·6 claims
- 1181US10351569B2Indoline analogs and uses thereofONCTERNAL THERAPEUTICS INC·Filed 2017·Granted Jul 16, 2019·2 cites·13 claims
- 1280US2022288023A1Indolinone compounds and uses thereofONCTERNAL THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1368US12187720B2Compounds for treatment of cancerONCTERNAL THERAPEUTICS INC·Filed 2021·Granted Jan 7, 2025·0 cites·16 claims
- 1465US2018256546A1Indolinone compounds and uses thereofONCTERNAL THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 1564US2026008849A1Antibody formulationsONCTERNAL THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1655US11465987B2Compounds for treatment of cancerONCTERNAL THERAPEUTICS INC·Filed 2016·Granted Oct 11, 2022·0 cites·16 claims
- 1755US2023070988A1Combinations of egfr inhibitors and ror1 inhibitors for the treatment of cancerONCTERNAL THERAPEUTICS INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ONCTERNAL THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →